-The U.S. Food and Drug Administration (FDA) has approved Bluebird bio’s gene therapy for the treatment of a rare neurological disorder, the company said late on Friday. “SKYSONA is the …
Topic:
Neurological
-
-
U.S. Attorney’s Office Files Lawsuit Against Flint Neurological Centre P.C. For Violating the Rights of Individuals Who Have Disabilities
by DOJ PressFLINT, MI — The U.S. Attorney’s Office for the Eastern District of Michigan today announced that it has filed a lawsuit against Flint Neurological Centre P.C., alleging that the medical …